Greenphire announced it has released new visual analytics functionality for its eClinicalGPS technology
Greenphire, a provider of payment technologies for the clinical trials industry, announced it has released new visual analytics functionality for its eClinicalGPS technology which aims to give clients the tools aggregate strategic data for more effective trial forecasting, planning, tracking, and quantitative assessment.
By linking key cost drivers like subject enrollment and site-level clinical activity to contract and other financial data, clients are able to have a clear picture of their finances in relation to the trial, so they can make more effective business decisions, in real-time, that ensure a trial is completed on-time and on-budget.
For further information on Greenphire and its solutions please email: [email protected] or visit www.greenphire.com.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.